Heart Failure Clinical Trial
Daxor – Blood Volume Analysis
The purpose of this study is to better understand blood volume status and whether knowledge of it can change and improve heart failure care.
The purpose of this study is to better understand measurements of various parameters of congestion, the most significant of which is blood volume analysis. Blood volume analysis (BVA) measures how much blood is in the investigator's arteries and veins and is performed by using an IV and injecting a small amount of a radioactive material (I 131-labeled albumin). The study also involves blood tests, urine tests, blood pressure monitoring, an ultrasound, and measurement of lung fluid volume (by way of a vest). There will also be a 30-day follow-up phone call to assess symptoms and discuss any changes in medication.
- Admission for acute decompensated heart failure to the cardiology service at Duke Hospital, Durham, North Carolina
Age < 18 years
Recent acute MI or hemodynamic instability: Acute MI (STEMI or Type I NSTEMI) within 7 days
Post heart transplantation or ongoing mechanical circulatory support
Progressive cardiogenic shock
Patients with Ventricular Assist Devices
End stage renal disease
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Durham North Carolina, 27710, United States
How clear is this clinincal trial information?
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.